Related Experiment Video
Updated: Feb 4, 2026

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
PTEN enhances the radiosensitivity of melanoma by inhibiting DNA-PKcs
Shengqian Zhu1, Haitao Xu1, Fu Shen2
1Department of Plastic and Reconstructive Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Background:
The phosphatase and tensin homolog (PTEN) is a classical tumor-suppressor gene. Its expression deficiency concurrently drives disease progression in approximately 30% of melanomas and is closely associated with radiotherapy tolerance. However, there is a lack of systematic evidence regarding whether and how PTEN regulates the radiosensitivity of melanoma.
Methods:
The expression of PTEN was validated using TCGA database, clinical tissue microarrays, and multiple melanoma cell lines. PTEN knockdown (PTEN-KD) and PTEN overexpression (PTEN-OE) stable cell lines were constructed using lentiviral vectors. CCK-8, colony formation assay, annexin V/PI flow cytometry, neutral comet assay, cell-cycle analysis, and Western blotting were used to assess the biological changes in cells after 0 Gy-8 Gy γ-ray irradiation (IR). A cell-derived xenograft model was established, and the tumor volume was observed after local 10 Gy IR for 28 days; in addition, H&E, Ki67, and TUNEL evaluations were performed.
Results:
The expression of PTEN in melanoma tissues and cell lines was significantly lower than that in normal controls. IR could induce a transient upregulation of PTEN followed by rapid downregulation. PTEN-OE significantly inhibited proliferation, reduced the clone survival rate, increased apoptosis, and weakened radiation-induced G2/M phase arrest; however, the opposite was true for PTEN-KD. Mechanistically, PTEN-OE inhibited the DNA-PKcs axis, reduced NHEJ-mediated rapid repair, and increased the persistent expression of γ-H2AX. PTEN-KD activated the p-ATM/p-Chk2 signaling. Animal experiments confirmed that the tumor volume in the PTEN-OE + IR group was significantly lower than that in the NC + IR group, with an expanded necrotic area, a decreased Ki67 index, and an increased TUNEL-positive rate.
Conclusion:
PTEN enhances the radiosensitivity of melanoma by inhibiting the DNA-PKcs signal, weakening NHEJ repair, and delaying cell-cycle recovery. PTEN can serve as a biomarker for radiotherapy response prediction and a target for sensitization intervention, providing an experimental basis for precise radiotherapy strategies for melanoma.
Insights
Phosphatase and tensin homolog (PTEN) deficiency worsens melanoma progression and radiotherapy tolerance. Restoring PTEN expression enhances melanoma radiosensitivity by inhibiting DNA repair pathways, suggesting PTEN as a biomarker and therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy Research
Background:
- Phosphatase and tensin homolog (PTEN) is a tumor suppressor gene implicated in melanoma progression.
- PTEN deficiency is linked to reduced radiotherapy tolerance in melanoma patients.
- The precise role of PTEN in regulating melanoma radiosensitivity remains unclear.
Purpose of the Study:
- To investigate the role of PTEN in modulating melanoma radiosensitivity.
- To elucidate the molecular mechanisms by which PTEN affects cellular response to radiation.
- To evaluate PTEN as a potential biomarker and therapeutic target for melanoma radiotherapy.
Main Methods:
- Validated PTEN expression using TCGA, tissue microarrays, and melanoma cell lines.
- Constructed PTEN knockdown (PTEN-KD) and overexpression (PTEN-OE) cell lines.
- Assessed radiosensitivity via CCK-8, colony formation, flow cytometry, comet assays, cell cycle analysis, Western blotting, and in vivo xenograft models.
Main Results:
- PTEN expression was significantly lower in melanoma tissues and cell lines compared to normal controls.
- PTEN overexpression inhibited proliferation, reduced survival, increased apoptosis, and weakened G2/M arrest post-irradiation.
- PTEN inhibited DNA-PKcs signaling and NHEJ repair, while PTEN knockdown activated ATM/Chk2 signaling, confirmed in vivo tumor growth reduction.
Conclusions:
- PTEN enhances melanoma radiosensitivity by suppressing DNA repair pathways and promoting cell cycle recovery.
- PTEN serves as a predictive biomarker for radiotherapy response in melanoma.
- Targeting PTEN offers a promising strategy for improving melanoma radiotherapy efficacy.
Related Concept Videos
Feedback Inhibition
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
The DNA Replication Fork
Enzyme Inhibition
Self-Evaluation: Self-Enhancement and Self-Verification
Inhibition of Cdk Activity

